Post Profile

New non-invasive assay may improve surveillance of heart and other solid-organ transplants

(Elsevier Health Sciences) A significant unmet need exists for non-invasive diagnostic tools to monitor transplant recipients, especially for early detection of active injury and rejection. A report in The Journal of Molecular Diagnostics describes a new non-invasive test that measures donor-derived cell-free DNA (dd-cfDNA) in plasma that has the potential to reduce complications and rejection, improving outcomes in transplant recipients.
read more


Related Posts

Significant Mortality Rate Among Adolescent Non-Adhering Heart Transplant Recipients

Health : Medical News Today

After receiving an organ transplant, patients must follow a regimented medication routine to maintain the health of their graft (transplanted organ). Failure to do so, known as non-adherence (NA), can result in life-threatening illn...

Assessing rejection risk for heart transplant patients

Health : Time: Healthland

A blood test may offer heart transplant patients a less invasive way to assess rejection risk, according to a study published online today in the New England Journal of Medicine. As with most organ donations, heart transplants can p...

Blood Test For Traces Of Donor's Genome May Improve Detection Of Heart Transplant Rejections

Health : Medical News Today

Heart transplant recipients and their physicians are likely more concerned with the function of the donated organ than with the donor's DNA sequences that tag along in the new, healthy tissue. However, researchers at the Stanford Un...

Minimally Invasive Alternative to Corneal Transplantation May Improve Outcomes in People with a Degenerative Eye Disease

Health : Newswise Medical News

An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology. Transplantation...

New Non-Invasive Assay May Improve Surveillance of Heart and Other Solid-Organ Transplants

Health : Newswise Medical News

Patients who have received a solid organ transplant require lifelong immunosuppressive therapy. The threat of transplant rejection due to insufficient drug therapy must be balanced against increased risks of infections and cancer fr...


Copyright © 2016 Regator, LLC